SDC1 and metastatic malignant neoplasm in the lymph nodes: The incidence of low expression of syndecan-1 was significantly higher in males (p = 0.042), in tumors of higher TNM stage (p = 0.045), and in patients positive for lymph node metastasis (p = 0.017) (Table 1).